HLA-DQ Testing for Celiac Disease
Order HLA-DQ genotyping that specifically tests for HLA-DQ2.5 (DQA10501, DQB10201), HLA-DQ8 (DQA103, DQB10302), HLA-DQ2.2 (DQA10201, DQB10202), and HLA-DQ7.5 (DQA105, DQB10301) alleles, and ensure the laboratory reports all alleles tested, not just a simplified positive/negative result 1.
Critical Testing Specifications
The most important aspect of HLA-DQ testing is understanding that not all commercial laboratories report the complete panel of celiac-associated alleles. Many labs only report simplified "DQ2/DQ8 positive or negative" results, which can miss important variants 1.
Specific Alleles That Must Be Evaluated:
- HLA-DQ2.5 (DQA10501, DQB10201) - highest risk variant
- HLA-DQ8 (DQA103, DQB10302) - second major risk variant
- HLA-DQ2.2 (DQA10201, DQB10202) - less common but celiac-associated
- HLA-DQ7.5 (DQA105, DQB10301) - present in 0.4-3.6% of celiac patients 2
- Half heterodimers - must be evaluated as they can confer celiac risk 1
When to Order HLA Testing
HLA testing is most valuable for its negative predictive value - a negative result essentially rules out celiac disease and prevents unnecessary gluten challenges and dietary restrictions 1, 3.
Primary Indications:
- Seronegative enteropathy with villous atrophy but negative celiac antibodies
- Patient already on gluten-free diet before complete diagnostic workup
- Equivocal small bowel biopsy findings (minor changes, not frank villous atrophy)
- Historic diagnosis without serologic confirmation, especially in young children diagnosed before modern serology 3
- Persistent symptoms with severe gluten reactions where gluten challenge would be poorly tolerated 1
Interpretation Framework
Negative HLA-DQ2/DQ8 Result:
- Excludes celiac disease with >99% certainty 4, 5
- Prevents unnecessary gluten challenge
- Allows discontinuation of gluten-free diet if already started
- Redirects diagnostic workup to other causes of enteropathy 1
Positive HLA-DQ2/DQ8 Result:
- Does NOT diagnose celiac disease - 30% of general population carries these genes but only 2-3% develop disease 1
- Indicates genetic susceptibility only
- Cannot stand alone as diagnostic criterion 1
- Requires correlation with serology and/or biopsy for diagnosis
Risk Stratification by Genotype:
- HLA-DQ2 homozygosity: 16.49-fold increased risk 6
- HLA-DQ8 homozygosity: 4.39-fold increased risk 6
- HLA-DQ2.5 heterodimer with DQB1*02 homozygosity: highest risk 7
Critical Pitfalls to Avoid
Laboratory reporting inadequacy: Before accepting a "negative" HLA result, you must verify that the laboratory actually tested for all four key variants (DQ2.5, DQ8, DQ2.2, DQ7.5) and evaluated for half heterodimers. Many commercial kits only detect DQ2.5 and DQ8, missing 0.4-3.6% of celiac patients who have DQ7.5 2, 1.
Timing error: HLA testing can be performed at any time regardless of gluten intake or immunosuppressive therapy, unlike serology and biopsy. This makes it particularly useful when patients have already modified their diet 1.
Over-interpretation of positive results: A positive HLA result in the absence of positive serology or villous atrophy does not justify a gluten-free diet recommendation. The positive predictive value is too low given the high population prevalence of these alleles 1, 3.
Practical Testing Algorithm
- Request complete allele reporting from the laboratory upfront - specify you need DQA1 and DQB1 alleles reported, not just "positive/negative"
- If result is negative, verify all four variants were tested (DQ2.5, DQ8, DQ2.2, DQ7.5)
- If result is positive, do not use this alone for diagnosis - proceed with or complete serologic and histologic evaluation
- For seronegative enteropathy cases, negative HLA definitively excludes celiac and redirects workup to other etiologies in Table 1 of the guidelines (autoimmune enteropathy, common variable immunodeficiency, medications like olmesartan, Crohn's disease, etc.) 1